Rev Esp Quimioter 2021;34(Suppl.1):52-56

Ventilatory support and corticosteroid therapy in SARS-CoV-2

FERNANDO MARTÍNEZ SAGASTI, ALBA PALAZÓN BLANCO, SANDRA CATALINA GARCÍA-PERROTE, PATRICIA ALONSO MARTÍNEZ

Published: 30 September 2021

http://www.doi.org/10.37201/req/s01.16.2021

It has been almost two years since COVID-19, a disease caused by a new coronavirus called SARS-CoV-2, was declared a pandemic by the World Health Organization. The entire scientific and medical community was put to the test during the following months to find the best therapeutic strategy to save lives. Although some antivirals and anti-inflammatory drugs are being tested in different clinical trials with some controversial results, this short review will focus on corticosteroids usefulness and ventilatory support principles, as they have become two essential therapeutic pillars for those patients who need hospital admission due to respiratory failure.

Rev Esp Quimioter 2021; 34(Suppl. 1):52-56 [Full-text PDF]